Interactome Bio featured at NCI Meeting on Solving Critical Problems in Cancer Control Using Spatial Science
KALAMAZOO, Mich., January 24, 2023 (Newswire.com) - Interactome Bio ('IB' or the 'Company'), a growing biotechnology organization, announced titles of 2 abstracts to be presented as oral presentations at the National Cancer Institutes Comprehensive Cancer Center Meeting on Solving Critical Problems in Cancer Control using Spatial Science on Jan. 18 to Jan. 19, 2023 in Los Angeles, California at the University of Southern California Norris Comprehensive Cancer Center. A portion of this work was completed in collaboration with the University of Chicago, Comprehensive Cancer Center. The oral presentations and abstracts covered various advances made in the Company's UCRShiny application. UCRShiny is a powerful tool that allows users to analyze geospatial cancer data to identify specific populations at risk, understand potential causes of increased cancer risks, and develop targeted interventions to reduce those risks. The tool allows users to visualize geospatial cancer data on a map with customizable layers and assess the impact of single or multiple variables on cancer outcomes using statistically intelligent AI.
Title: UCR-Shiny: A GEO INELEGANT APPROACH TO CANCER DISPARITY
Presenter: Mohammad Abbasi
Session: C2B
Title: UC4IP: University of Chicago Comprehensive Cancer Center Catchment Area Informatics
Platform
Presenter: Mohammad Abbasi
Session: C2B
Sheena Toma
Public Relations
support@interactomebio.com
(224)254-0956
Original Source: Interactome Bio Features GIS Tool and Presents at the NCI Meeting: Solving Critical Problems in Cancer Control Using Spatial Science
